Stay updated with breaking news from Detect Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection.
Alzheimer's disease is the most common cause of dementia in the UK, a condition that affects almost one million people.
Medical laboratories company Quest Diagnostics has made a blood test assessing biomarkers of Alzheimer's disease commercially available to consumers in the United States.
The first direct-to-consumer blood test for an early Alzheimer’s indicator is now available from Quest Diagnostics, revealing the risk for the disease years before symptoms appear.
The test from Quest Diagnostics looks at a certain brain protein is known to contribute to the condition.